top of page

Biopharma Daily Stock Updates - 01/06/21

Updated: Jan 13, 2021

$XBI $143.32 (+2.04%) 📈


$IMRA (-37.97%) - Imara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with Sickle Cell Disease

$RDHL (-3.76%) - RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation for NTM Disease

$RDUS (+15.76%) - Radius Health, Inc. Announces Acquisition of Orphan Disease Program

$SELB (+8.22%) - Selecta Biosciences Announces Data in Non-Human Primates, FurtherValidating Multiple Potential Benefits of the ImmTORTM Platform in Gene Therapy

$ZNTL (-6.54%) - Zentalis Pharmaceuticals Announces the Initiation of Multiple Early-Stage Clinical Trials


$RGNX (+8.39%) - Offering

bottom of page